Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$530M |
| 2 |
AbbVie
ABBV
|
+$429M |
| 3 |
Boston Scientific
BSX
|
+$292M |
| 4 |
Snap
SNAP
|
+$241M |
| 5 |
Royalty Pharma
RPRX
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$327M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$295M |
| 3 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$294M |
| 4 |
Sysco
SYY
|
+$209M |
| 5 |
Shopify
SHOP
|
+$176M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.65% |
| 2 | Healthcare | 19.7% |
| 3 | Consumer Discretionary | 10.81% |
| 4 | Financials | 9.9% |
| 5 | Communication Services | 8.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRO
1126
DELISTED
Marathon Oil Corporation
MRO
| $923K | ﹤0.01% |
150,910
-56,999
| -27% | -$315K |
|
1127
Warrior Met Coal
HCC
$4.09B
| $919K | ﹤0.01% |
59,717
+30,309
| +103% | +$413K |
|
1128
Zillow
ZG
$7.85B
| $913K | ﹤0.01% |
+15,886
| New | +$783K |
|
1129
Toll Brothers
TOL
$14.2B
| $911K | ﹤0.01% |
27,962
-44,385
| -61% | -$1.21M |
|
|
CVGW
1130
DELISTED
Calavo Growers
CVGW
| $905K | ﹤0.01% |
14,383
+2,370
| +20% | +$142K |
|
1131
Fair Isaac
FICO
$32.6B
| $905K | ﹤0.01% |
2,166
-12,124
| -85% | -$4.42M |
|
1132
Itaú Unibanco
ITUB
$90.2B
| $897K | ﹤0.01% |
263,080
-97,353
| -27% | -$316K |
|
1133
APA Corp
APA
$12.8B
| $896K | ﹤0.01% |
66,338
-361,815
| -85% | -$4.13M |
|
1134
Elbit Systems
ESLT
$36.3B
| $881K | ﹤0.01% |
6,426
-10,880
| -63% | -$1.47M |
|
1135
PG&E
PCG
$39.2B
| $854K | ﹤0.01% |
96,277
-28,818
| -23% | -$314K |
|
|
BPYU
1136
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
| $854K | ﹤0.01% |
85,704
| – | – |
|
1137
Textron
TXT
$14.9B
| $851K | ﹤0.01% |
25,854
-1,080
| -4% | -$31.9K |
|
1138
Ingevity
NGVT
$2.49B
| $813K | ﹤0.01% |
+15,466
| New | +$734K |
|
1139
Vanguard FTSE Europe ETF
VGK
$30B
| $809K | ﹤0.01% |
+16,076
| New | +$759K |
|
1140
Wyndham Hotels & Resorts
WH
$5.61B
| $797K | ﹤0.01% |
18,692
+6,772
| +57% | +$276K |
|
|
SBNY
1141
DELISTED
Signature Bank
SBNY
| $795K | ﹤0.01% |
7,435
-10,629
| -59% | -$1.05M |
|
|
SMAR
1142
DELISTED
Smartsheet Inc.
SMAR
| $781K | ﹤0.01% |
+15,344
| New | +$781K |
|
1143
Castle Biosciences
CSTL
$730M
| $777K | ﹤0.01% |
+20,610
| New | +$704K |
|
1144
SiteOne Landscape Supply
SITE
$4B
| $769K | ﹤0.01% |
6,747
-5,934
| -47% | -$552K |
|
1145
CrowdStrike
CRWD
$183B
| $763K | ﹤0.01% |
+30,456
| New | +$611K |
|
1146
Vanguard FTSE Pacific ETF
VPL
$7.79B
| $749K | ﹤0.01% |
+11,768
| New | +$710K |
|
|
NBL
1147
DELISTED
Noble Energy, Inc.
NBL
| $740K | ﹤0.01% |
82,543
-31,151
| -27% | -$278K |
|
1148
Sabra Healthcare REIT
SBRA
$5.58B
| $738K | ﹤0.01% |
51,165
-19,807
| -28% | -$260K |
|
1149
CareTrust REIT
CTRE
$10B
| $737K | ﹤0.01% |
42,967
+5,808
| +16% | +$101K |
|
1150
Vanda Pharmaceuticals
VNDA
$301M
| $722K | ﹤0.01% |
63,106
+30,237
| +92% | +$342K |
|
Similar funds
Janus Henderson Group's Q2 2020 Portfolio in Review
As of Q2 2020, Janus Henderson Group held 1,423 positions worth $178B, up 23% from $145B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Janus Henderson Group's Q2 2020 filing shows 132 new, 511 increased, 643 reduced and 125 closed positions. Its largest new stake was Royalty Pharma: 4,507,138 shares worth $219M. The largest sale was Boeing, an estimated $327M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q2 2020 buy was Royalty Pharma: 4,507,138 shares worth $219M.
- Janus Henderson Group added most to T-Mobile US in Q2 2020, an estimated $530M increase.
- Janus Henderson Group's biggest Q2 2020 reduction was Boeing, cutting an estimated $327M.
- Janus Henderson Group fully exited Allergan plc in Q2 2020, selling an estimated $128M.
- Janus Henderson Group's ten largest holdings make up 23% of its $178B portfolio in Q2 2020.
- Janus Henderson Group opened 132 new positions and closed 125 in Q2 2020.
- Janus Henderson Group's portfolio value rose 23% quarter-over-quarter to $178B.
Based on Janus Henderson Group's 13F filing for Q2 2020, filed 14 Aug 2020.